Print

Universal Influenza Immunization Program (UIIP)

The following provides information about the Ontario Ministry of Health and Long-Term Care’s (the ministry’s) Universal Influenza Immunization Program (UIIP) for the 2017-2018 influenza season. The official launch of the UIIP will occur on October 23rd, 2017. Influenza immunization for the general population through community-based influenza immunization clinics will begin on or after the UIIP launch date. As in previous years, immunization of high priority groups should begin as soon as influenza vaccine is available.

Recommended Influenza Vaccine Recipients

All individuals aged 6 months or older who live, work or attend school in Ontario are eligible and recommended for the publicly funded influenza vaccine in Ontario (provided that they have no contraindications to the vaccine)

Individuals at high risk of influenza-related complications or more likely to require hospitalization:

The publicly funded influenza vaccines available through the 2017/18 UIIP are listed in the table below:

Vaccine Trivalent Inactivated Vaccines (TIVs)* Quadrivalent Inactivated Vaccines (QIVs) Quadrivalent - Live Attenuated Vaccine
(Q-LAIV)**
Fluviral® Influvac® FluLaval Tetra® Fluzone® Quadrivalent ~ Flumist® Quadrivalent
Dosage 0.5mL 0.5mL 0.5mL 0.5mL 0.2mL
(0.1mL in each nostril)
Format Multi-dose vial Pre-filled syringes Multi-dose vial

Multi-dose vial
Pre-filled
syringe

Pre-filled single use sprayer
Administration Route Intramuscular Injection Intramuscular Injection Intramuscular Injection Intramuscular Injection Intranasal spray

Age Indications
(per product monograph)

6 months 3 years 6 months 6 months 2 to 59 years
Potential Allergens

Egg Protein^ Formaldehyde
Thimerosal

Egg Protein^ Chicken Protein
Formaldehyde
Gentamicin

Egg Protein^ Formaldehyde
Thimerosal

Multi-dose:

Egg Protein^ Formaldehyde
Thimerosal

Pre-filled:

Egg Protein
Formaldehyde

Arginine
Egg Protein^
Gelatin
Gentamicin

Post-Puncture Shelf Life 28 days N/A 28 days

Multi-dose:
Up to expiry date indicated
on vial label

Pre-filled:
N/A

N/A

Package Dimensions in cm (l x w x h)

3 x 3 x 7 18.8 x 15.2 x 1.7 3 x 3 x 6 Multi-dose:
3.6 x 2.9 x 6

Pre-filled:
10.4 x 8.9 x 3.8
10.6 x 17.6 x 2.9

Note: Additional information is available in the product monograph
* Unless specifically requested, the TIVs are primarily targeted to adults 18 years of age and older.
**The National Advisory Committee on Immunization (NACI) has removed the preferential recommendation for the use of live attenuated vaccine in children 2 to under 6 years of age
^ NACI has concluded that egg allergic individuals may be vaccinated against influenza using live attenuated influenza vaccine (see ADDENDUM – LAIV Use in Egg Allergic Individuals-Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2017-18.

~Fluzone ® Quadrivalent and Fluzone High Dose ® are two different products. Please see product monographs for further information.

Important Notes:

Vaccines for Specific Age Groups:

Recommended Vaccine
Age Group TIV Influvac TIV Fluviral QIV FluLaval QIV Fluzone QIV Flumist
6 to 23 months
Yes
Yes
2 to17 years
Yes
Yes
Yes
18 years
Yes
Yes
Alternative Vaccine (if requested or if recommended vaccine is not available)
Age Group TIV Influvac TIV Fluviral QIV FluLaval QIV Fluzone QIV Flumist
6 to 23 months
Yes
     
2 to17 years
Yes (3 years)*
Yes
     
18 years
     

Note:

*Influvac is indicated for those 3 years of age and older in the product monograph

Influenza Vaccine Ordering

Health Care Providers Location Order vaccine from
All providers with the exception of pharmacists outside Toronto
(not within the "M" potal code)
Local public health unit by using the Influenza Vaccine Order Form for the UIIP
All providers within Toronto
(within the "M" area code)
Ontario Government Pharmaceutical and Medical Supply Service (OGPMSS) by faxing the Influenza Vaccine Order Form for the UIIP to 416-327-0818

Pharmacists

outside Toronto
(not within the "M" potal code)
Refer to Pharmacies with Trained Pharmacists section below for details on vaccine ordering

The TIV products (Influvac®, and Fluviral®) and QIV products (FluLaval Tetra® and Fluzone® Quadrivalent®) will be distributed based on availability (requests for specific TIV products or QIV products are not permitted). Each TIV product and each QIV product are considered equivalent with respect to their approved indications for use. Please consult your local public health unit to determine vaccine availability for your clinic.

Influenza vaccine is received in Ontario intermittently throughout late September and October, and distributed throughout influenza season. As in previous years, vaccine distribution for the 2017/2018 influenza season will begin around late September to late October for the immunization of high priority groups . Community-based influenza immunization clinics for the general population will begin when the UIIP is officially launched in late-October:

All required fields of the Influenza Vaccine Order Form for the UIIP must be completed to ensure orders are filled.

Important Notes:

Program Specific Information for the Various UIIP Participants

Additional Resources and Information

Questions

For More Information

Please e-mail uiip.moh@ontario.ca or call Service Ontario, INFOline at 1 877-844-1944